Dr. Catherine A. Wittman, MD

Dr. Wittman practices at National Jewish Health in Denver, Colorado, part of National Jewish Health.

Dr. Wittman's NPI, 1144412610, was assigned on August 17, 2007. Dr. Wittman holds Colorado license 51031.

Dr. Wittman's primary practice is National Jewish Health, at 1400 Jackson St, Denver, CO 80206 in Denver County. The practice phone is (303) 388-4461.

Dr. Wittman's primary practice is National Jewish Health in Denver, Colorado, part of National Jewish Health. Dr. Wittman is also affiliated with Saint Joseph Hospital. The medical group on file is National Jewish Health. Dmand AI also links Dr. Wittman to 2 more hospitals, each named with a free account. Dr. Wittman's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wittman practices, 4 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Wittman's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dmand AI has Dr. Wittman's licenses on file in 2 states: Colorado and Pennsylvania.

CMS data shows 285 Medicare services from Dr. Wittman across 6 procedure codes in 2024, for 167 Medicare patients. Medicare paid $31,843 for them.

CMS counts 167 Medicare patients who saw Dr. Wittman in 2024. The largest group is 65 to 74, with 75 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 22% are also on Medicaid. Their average risk score is 1.79, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Wittman's median patient age at 74, with 60% women.

In 2024, Dr. Wittman wrote 729 Medicare Part D claims for 121 patients. 44% of them were for generic drugs. CMS names the drug for 617 of them, across 22 drugs with 11 or more claims each, at $545,938 in total drug cost. In 2023, CMS named 597 claims across 23 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Wittman for performance year 2024, reported as part of a group. Dr. Wittman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Wittman as offering telehealth.

Dmand AI links 2 papers to Dr. Wittman, published from 2013 to 2014. The most frequent topics are HIV Infections. Dr. Wittman's most frequent co-authors are Matthew Ray Gingo, Emily Siu Clausen, MD and Khaled Fernainy, MD.

CMS Open Payments shows 12 general payments to Dr. Wittman from 8 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 100% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $128.